Epistaksis Nedeniyle Hastanede Yatarak Tedavi Edilen Hastaların Retrospektif Analizi: Öngörüler ve Çıkarımlar
Retrospective study on hospitalized patients with epistaxis: Insights and implications
Epistaxis, commonly encountered in the Otolaryngology practice, refers to bleeding that occurs as a result of vascular pathologies and coagulation disorders. It can develop due to traumatic, iatrogenic, or spontaneous etiologies. In our study, we aim to retrospectively examine the epistaxis patients treated in our clinic to investigate the etiology causing epistaxis, associated diseases, and the use of anticoagulants-antiplatelets. Additionally, we plan to evaluate hemogram and coagulation parameters. The study included patients diagnosed with epistaxis and admitted for treatment at Samsun Education and Research Hospital ENT Clinic between 2019 and 2022. A retrospective analysis of the patients' medical records was conducted to gather data on demographic characteristics, comorbidities, medications used regularly, laboratory values, and clinical findings. A total of 130 patients were included in the study. No statistically significant difference was observed between the location of the bleeding focus and gender, presence of hypertension, use of antihypertensive medication, or anticoagulant use. When comparing patients with and without antiplatelet-anticoagulant use, a significantly longer nasal packing duration was found in patients who used these medications. In terms of the need for electrocauterization, statistically significant higher intervention rates were observed in patients who did not use anticoagulant medication. Our study identified a higher rate of surgical intervention in hospitalized epistaxis patients, potentially due to the inclusion of more severe cases requiring specialized care. Further research is needed to investigate the factors influencing the need for surgical management and to develop appropriate guidelines for the management of different severities of epistaxis.
___
- 1. Yavuz R., Yavuz HB. (2021). Epistaksis şiddetine göre hastaların retrospektif karşılaştırması. Kulak Burun Boğaz Uygulamaları. 2021; 9(2), 53-59.
- 2. Send T., Bertlich M., Eichhorn KW., Ganschow R., Schafigh D., Horlbeck F., et al. Etiology, management, and outcome of pediatric epistaxis. Pediatr Emerg Care. 2021 Sep 1;37(9):466-470. doi: 10.1097/PEC.0000000000001698
- 3. Özgür A., Birinci M., Coşkun Z., Terzi S., Erdivanlı Ö., Demirci M., et al. A cross-sectional study of epistaxis: Etiologic and clinical characteristics. Journal of Clinical and Analytical Medicine. 2016; vol.7, no.6, pp.804-806. Doi: 10.4328/jcam.4336
- 4. Kaygusuz İ., Karlıdağ T., Keleş E., Yalçın Ş., Alpay HC.,Sakallıoğlu Ö. Hastaneye yatırılarak tedavi edilen 68 epistaksisli hastanın retrospektif analizi. Fırat Tıp Dergisi. 2004; 9(3), 82-85.
- 5. Page C., Biet A., Liabeuf S., Strunski V.,Fournier A. Serious spontaneous epistaxis and hypertension in hospitalized patients. Eur Arch Otorhinolaryngol. 2011 Dec;268(12):1749-53. doi: 10.1007/s00405-011-1659-y.
- 6. André N., Klopp-Dutote N., Biet-Hornstein A., Strunski V., Page C. (2018). Cardiovascular risk and severity factors in patients admitted to hospital for spontaneous epistaxis. Eur Ann Otorhinolaryngol Head Neck Dis. 2018
Apr;135(2):119-122. doi: 10.1016/j.anorl.2017.11.004.
- 7. Koksal O., Durak VA. Yeni Kuşak Oral Antikoagülanlara Bağlı Kanamalarda Acil Servis Yönetimi. Anatolian Journal of Emergency Medicine. 2020;3(2); 62-65.
- 8. Ağırbaşlı M., Güvenç H., Çinçin A. Antitrombosit tedavide yeni ilaçlar. Türk Kardiyoloji Derneği Arşivi. 2010;38(5), 369-378.
- 9. Pollice PA, Yoder MG. Epistaxis: A retrospective review of hospitalized patients. Otolaryngology–Head and Neck Surgery. 1997;117(1):49-53. doi:10.1016/S0194-59989770205-5
- 10. Womack JP., Kropa J., Jimenez Stabile M. Epistaxis: Outpatient Management. American family physician. 2018;98(4), 240–245.
- 11. Tabassom A., Cho JJ. Epistaxis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan.2022 Sep 12.PMID: 28613768 Bookshelf ID: NBK435997